WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-75
SponsorAlexandra Hospital

About this trial

Public health priorities have shifted towards disease prevention, emphasising health promotion and lifestyle interventions to reduce disease burden. Despite global efforts, the prevalence of chronic diseases remains high, with lifestyle factors such as alcohol consumption, diet, smoking, obesity, and sedentary behaviour playing significant roles. In Singapore, suboptimal lifestyle behaviours are common, contributing to a high incidence of chronic conditions. Metabolic syndrome (MetS), linked to obesity, poses a growing societal burden due to its association with cardiovascular risks. Disparities exist in the delivery of lifestyle interventions among healthcare providers (HCPs), with many patients receiving inadequate guidance. Digital health coaching, incorporating wearable technology, offers promising solutions to bridge these gaps, providing personalised, real-time support and feedback to improve lifestyle behaviours and prevent disease progression. Challenges such as time constraints, lack of feedback, and limited support can be addressed through remote monitoring and tailored interventions, making scalable population-level interventions feasible.

Eligibility criteria

Qualifiers

21-75 years old

Elevated blood pressure

Overweight (BMI>=23kg/m2)

Pre-diabetes, OR

Disqualifiers

Patients who have a medical condition that prevented participation in physical activity

Patients who have current diagnosis or history of eating disorder, depression

Patients who are currently pregnant or planning to become pregnant in the next 6 months

Patients who are currently participating in a weight loss programme (commercial, medically supervised, or research study)

Trial design

Treatments tested in this trial

  • Smart watch
  • Dashboard with nudging system
  • Digital Health Coach (DHC)

Treatment groups

1,700 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Alexandra Hospital

Lead sponsor

National University of Singapore

Collaborator